In a parallel randomised trial, O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET led to comparable survival outcomes to contrast-enhanced T1-weighted (CE-T1) MRI for re-irradiation planning in patients ...
Hypoxia, or insufficient oxygen supply, plays a critical role in solid tumor growth and treatment resistance. The tumor microenvironment influences both the aggressiveness of a tumor and its ability ...
Current PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consistent signals from both PET and MRI. In healthy kidneys, the center ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
Whole-body diffusion-weighted MRI scans may be as effective as traditional PET-CT scans for staging cancer tumors in children and young adults without exposing patients to ionizing radiation, ...
A phase 3 trial found that PSMA PET-CT after equivocal MRI halves the prostate biopsy rate in men at high clinical risk for prostate cancer. In men with high clinical risk and equivocal prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results